Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS

KI Stevens, E Frangou, JI Shin… - Nephrology Dialysis …, 2022 - academic.oup.com
Patients with immune-mediated kidney diseases are at increased risk of severe coronavirus
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …

Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis

KT Tang, BC Hsu, DY Chen - Biomedicines, 2022 - mdpi.com
Background: Vaccination is one of the most important measures worldwide to halt the
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …

COVID-19 infection among vaccinated and unvaccinated: Does it make any difference?

S Fatima, A Zafar, H Afzal, T Ejaz, S Shamim… - PloS one, 2022 - journals.plos.org
Objective There is a probability that vaccination may lead to reduction in the severity and
complications associated with COVID-19 infection among hospitalized patients. This study …

American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 4

JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2022 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

American College of Rheumatology Guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5

JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2023 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis

R Cordtz, S Kristensen, R Westermann, K Duch… - …, 2023 - academic.oup.com
Objectives The objectives of this study were to investigate the incidence of COVID-19
hospitalization in unvaccinated and vaccinated patients with RA compared with matched …

Inflammatory Response in COVID-19 Depending on the Severity of the Disease and the Vaccination Status

F Trofin, EV Nastase, MF Roșu, AC Bădescu… - International journal of …, 2023 - mdpi.com
The aim of this study was to analyze the serum concentration of interleukin-6 (IL-6), C-
reactive protein (CRP), D-dimer, lactate dehydrogenase (LDH), ferritin, and procalcitonin in …

Immunogenicity, breakthrough infection, and underlying disease flare after SARS-CoV-2 vaccination among individuals with systemic autoimmune rheumatic diseases

JJ Paik, JA Sparks, AHJ Kim - Current Opinion in Pharmacology, 2022 - Elsevier
Many patients with systemic autoimmune rheumatic diseases (SARDs) require
immunosuppression to reduce disease activity, but this also has important possible …

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

Z Szekanecz, Z Vokó, O Surján, É Rákóczi… - Frontiers in …, 2023 - frontiersin.org
Introduction In Hungary, the HUN-VE 3 study determined the comparative effectiveness of
various primary and booster vaccination strategies during the Delta COVID-19 wave. That …

Comparison of immunogenicity and safety of inactivated, adenovirus-vectored, and heterologous adenovirus-vectored/mRNA vaccines in patients with systemic lupus …

T Assawasaksakul, T Lertussavavivat… - Vaccines, 2022 - mdpi.com
Background: Impaired immune responses to COVID-19 vaccines have been observed in
autoimmune rheumatic disease patients. Determining the most effective and safe vaccine …